This is a court order from the U.S. District Court for the Southern District of New York, dated July 16, 2019, in the case of United States v. Jeffrey Epstein. The order, signed by Judge Richard M. Berman, grants the motion for attorney Martin G. Weinberg of Boston, MA, to be admitted Pro Hac Vice, allowing him to serve as co-counsel for the defendant, Jeffrey Epstein.
This is a court order from the U.S. District Court for the Southern District of New York, filed on July 15, 2019, in the case of United States v. Jeffrey Epstein. The order, signed by Judge Richard M. Berman, grants the motion for attorney Martin G. Weinberg to be admitted "Pro Hac Vice," allowing him to practice in this specific case as co-counsel for the defendant, Jeffrey Epstein.
This document is a legal motion filed on July 15, 2019, in the Southern District of New York (Case 1:19-cr-00490-RMB). Attorney Martin G. Weinberg requests admission Pro Hac Vice (permission to practice in this specific jurisdiction for this case) to serve as co-counsel for the defendant, Jeffrey Epstein. Weinberg confirms his good standing with the Massachusetts Bar and provides his contact information in Boston.
This is a court order from the U.S. District Court for the Southern District of New York, filed on July 15, 2019, in the case of United States v. Jeffrey Epstein. The order, issued by Judge Richard M. Berman, grants attorney Martin G. Weinberg's motion for admission *pro hac vice*. This allows Weinberg, a member of the Massachusetts bar, to officially act as co-counsel for the defendant, Jeffrey Epstein, in this specific criminal case.
This document outlines possible solutions for restructuring Medicare & Medicaid, focusing on economic factors. Part 1 discusses cost-sharing mechanisms like co-pays and co-insurance, analyzing their impact on consumer behavior and incentives. Part 2 details reimbursement reform options such as bundled payments, global payment systems, pay-for-performance, and Accountable Care Organizations (ACOs), emphasizing a shift from quantity to quality of care.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity